[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial

Proof of concept

A first preclinical study proves the effectiveness of Hemerion therapeutics approach on glioblastoma (GBM) human cell lines. The experiments associated a photoactivatable drug and an innovative photonic system.